Overview
1. Executive Summary (Confidence: high)
Agappe Diagnostics (ADL) is one of the fastest-growing IVD companies globally, marking over 30 years of excellence in 2025. From its state-of-the-art 200,000 square-foot manufacturing facility in Kerala, India, the company has successfully expanded its footprint to over 90 countries. With revenues in the range of INR 500-750 crore and a strong distribution network of over 1,000 partners, Agappe has established itself as the second-largest manufacturer of clinical chemistry reagents in India. By adhering to the principles of Quality, Innovation, and Affordability, the company has moved from an imports-only model to a fully integrated, technology-driven pioneer in clinical chemistry, hematology, and molecular diagnostics.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.